Guaifenesin Tablet, Extended Release
Product Images NDC 11822-4260

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Guaifenesin (NDC 11822-4260). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rite Aid Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (1200 mg Blister Carton (14 (1 x 14) Tablets))

Package Label-principal Display Panel (1200 mg Blister Carton (14 (1 x 14) Tablets))
This is a drug information label of a medicine that contains Guaifenesin Extended-Release Tablets 1200 mg, an expectorant that is used to relieve chest congestion and thin and loosen mucus. The label claims to be comparable to the active ingredient in Maximum Strength Mucinex®. It contains drug facts, dosage instructions, inactive ingredients, and warnings. The drug should not be used for children below 12 years, and pregnant or breastfeeding women should consult their healthcare professional before use. The label is distributed by Soaps drug in 2016 and manufactured by Cipla Ltd in India.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.